Specialised Therapeutics Distributing Oncotype DX Breast Cancer Assay in Australia, New Zealand | GenomeWeb

NEW YORK (GenomeWeb News) – Biopharmaceutical firm Specialised Therapeutics Australia announced today a deal for the distribution of Genomic Health's Oncotype DX breast cancer assay in Australia and New Zealand.

Financial and other terms of the agreement, which took effect Jan. 1, were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.